GlassScriptPhysician profile
Andrew L Keller
NPI 1508154915
$6,987.47
in general payments reported to CMS, 2019-2025
36 companies · $888 in 2025
The $888 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $681 · 2022: $1,402 · 2023: $2,889 · 2024: $1,128 · 2025: $888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,106 · Education: $1,006 · Travel and Lodging: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,106.35 |
| Education | $1,005.81 |
| Travel and Lodging | $791.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,180.07 | 2021-2024 | Senza |
| Mml US, INC. | $1,092.32 | 2021-2025 | Reactiv8 |
| Astrazeneca Pharmaceuticals LP | $483.31 | 2021-2025 | Lokelma, Fasenra |
| Collegium Pharmaceutical, INC. | $384.62 | 2023-2025 | Belbuca, Xtampza |
| Boston Scientific Corporation | $289.26 | 2021-2025 | Wavewriter Alpha Prime 16, Na |
| Otsuka America Pharmaceutical, INC. | $270.51 | 2023-2024 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Genentech USA, INC. | $246.17 | 2021-2024 | Xolair |
| Lundbeck LLC | $226.25 | 2022-2025 | Vyepti |
| Abbvie INC. | $221.25 | 2021-2024 | |
| Medtronic, INC. | $211.24 | 2023-2025 | Hawkone, Intellis Adaptivestim, Synchromedii |
| Tersera Therapeutics LLC | $166.10 | 2023-2025 | Prialt |
| Lilly USA, LLC | $139.57 | 2021-2023 | Emgality, Reyvow |
| Amgen INC. | $134.83 | 2021-2023 | Evenity, Prolia |
| Glaxosmithkline, LLC. | $121.61 | 2023 | Arexvy |
| Spr Therapeutics, INC | $107.82 | 2022-2023 | Sprint Pns System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $95.29 | 2025 | Qutenza |
| Scilex Pharmaceuticals INC. | $83.37 | 2022-2024 | Ztlido |
| Daiichi Sankyo INC. | $69.18 | 2024 | |
| Painteq LLC | $56.06 | 2022-2023 | Painteq |
| Saluda Medical Americas, INC. | $47.11 | 2023-2025 | Evoke, Evoke Scs |
| Vertos Medical, INC. | $36.72 | 2024 | Mild Device Kit |
| Relievant Medsystems, INC. | $33.54 | 2021 | |
| Hikma Pharmaceuticals USA | $30.10 | 2022-2024 | Kloxxado |
| Metacel Pharmaceuticals LLC | $28.34 | 2025 | Ozobax |
| Biotronik Nro, INC. | $25.50 | 2025 | Prospera |
| Kowa Pharmaceuticals America, INC. | $24.87 | 2022 | |
| Curonix LLC | $24.49 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Avanos Medical | $22.16 | 2024 | Standard Rf Disposables |
| Arbor Pharmaceuticals, INC. | $21.62 | 2021 | |
| Nalu Medical, INC. | $20.25 | 2023 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $19.56 | 2025 | |
| Biodelivery Sciences International, INC. | $15.65 | 2021 | |
| Almatica Pharma LLC | $15.54 | 2021 | |
| Abbott Laboratories | $15.49 | 2023 | Proclaim |
| Convatec INC. | $14.25 | 2025 | |
| Horizon Therapeutics Plc | $13.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Keller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.